UAAMay 1, 2026 at 7:43 AM UTCConsumer Durables & Apparel

Under Armour: Waiting on Turnaround, Downside Limited at $6.98

Read source article

What happened

Under Armour's Q3 FY2026 results showed revenue down 5% and gross margin compression to 44.4%, split between tariff impacts (~200bps) and promotional pricing (~140bps), confirming the turnaround is still in its early stages. Management is targeting stabilization by fiscal 2027, with restructuring expected to conclude next quarter, but the company has made significant cost reductions and SKU rationalization. The DeepValue report maintains a WAIT rating with an attractive entry at $5.75 and a base value of $6.75, implying limited near-term upside at the current $6.98 price. The next catalyst is Q4 FY2026, which must show a 'considerable decline' in SG&A and evidence that North America promotional pressure is easing. Without simultaneous proof of cost discipline and improving price realization, the stock is likely to remain range-bound, with downside protected only by a manageable debt maturity profile.

Implication

Investors should maintain a cautious stance, as Under Armour's turnaround remains unproven on a GAAP basis. The DeepValue report's base case of $6.75 suggests limited upside from $6.98, with a bear case of $4.75 if promotional pressure persists. The Q4 FY2026 report (due mid-May) is the key inflection point: if SG&A declines considerably and gross margin shows reduced promotional impact, the WAIT rating could upgrade to a BUY. Conversely, failure to deliver on these fronts would validate the bear case and suggest further downside. Given the high conviction (3.5/5) and a clear re-assessment window, patience is warranted until the two proof-points are confirmed.

Thesis delta

The new article reinforces the existing thesis that Under Armour is a 'messy but progressing' turnaround requiring near-term operating proof. No material shift in the narrative; the DeepValue report had already incorporated these Q3 results and guided expectations. The delta is that the timeline to prove execution is now compressed to a single quarter (Q4 FY2026), increasing binary risk around the mid-May report.

Confidence

high